|1.||Jayakumar, Thanasekaran: 3 articles (01/2015 - 01/2013)|
|2.||Sheu, Joen-Rong: 2 articles (01/2015 - 01/2013)|
|3.||Wakabayashi, Hidetsugu: 2 articles (11/2010 - 11/2003)|
|4.||Sakagami, Hiroshi: 2 articles (11/2010 - 11/2003)|
|5.||Hashimoto, Ken: 2 articles (11/2010 - 11/2003)|
|6.||Chang, Chao-Chien: 1 article (01/2015)|
|7.||Huang, Chien-Hsun: 1 article (01/2015)|
|8.||Lu, Shing-Hwa: 1 article (01/2015)|
|9.||Thomas, Philip Aloysius: 1 article (01/2015)|
|10.||Kolnagou, Annita: 1 article (01/2015)|
10/01/1986 - "The concentrations of these drugs needed for this decrease were nearly comparable to those needed to suppress isoprenaline-tropolone-induced ventricular fibrillation (Sono et al. 1985a). "
10/01/1985 - "There was a significant correlation for dependence of duration of ventricular fibrillation on the isoprenaline content of rat hearts perfused with various extraneuronal uptake inhibitors in the presence of tropolone (correlation coefficient [r] = 0.62, P less than 0.001). "
10/01/1985 - "The accumulation of isoprenaline was significantly increased and the duration of ventricular fibrillation was significantly prolonged by the presence of tropolone (100 mumol/l). "
10/01/1985 - "When extraneuronal uptake inhibitors such as normetanephrine (100 mumol/l), 3-O-methylisoprenaline (100 mumol/l) or phenoxybenzamine (1 mumol/l) were added to the perfusion fluid containing 3H-isoprenaline (1 mumol/l) and tropolone (100 mumol/l), the accumulation of isoprenaline was significantly decreased, the incidence of ventricular fibrillation was significantly reduced and the duration of ventricular fibrillation was significantly shortened. "
07/01/1987 - "As part of a study on the structure-activity relationship of antitumor-active tropolone derivatives, a series of bistropone analogues, related to potently active bistropolone 1a, were synthesized and tested for their antitumor activity in in vitro (KB cell) and in vivo (leukemia P388 in mice) systems. "
01/24/1992 - "Bistropolone derivatives (4-12) containing differing lengths of linkage between the two tropolone rings were prepared and examined for their antitumor activity in in vitro (KB cell) and in vivo (leukemia P388 in mice) systems. "
|4.||Liver Cirrhosis (Hepatic Cirrhosis)
02/01/1993 - "Mechanism of thrombocytopenia in liver cirrhosis: kinetics of indium-111 tropolone labelled platelets."
02/01/1993 - "Using indium-111 tropolone-labelled platelets, a study of platelet kinetics was performed on the basis of the relationship between platelet count, platelet survival time, platelet dynamics, platelet-associated immunoglobulin G (PA-IgG) and splenic volume in 31 patients with liver cirrhosis and a platelet count of less than 100 x 10(9)/l. "
|5.||Crohn Disease (Crohn's Disease)
06/01/1995 - "In the present study, leucocytes obtained from patients suffering from Crohn's disease, were isolated and labelled with 99mTc-HMPAO or labelled according the new 99mTc-tropolone procedure using 9.8 mM tropolone, 1 microM stannous chloride and 0.8 mM potassium borohydride (KBH4) at pH 5.5-6. Labelling efficiency with 99mTc-tropolone yielded 92 +/- 3%, which is higher compared to the 99mTc-HMPAO labelling procedure (64 +/- 13%) using 10(8) of leucocytes. "
|7.||Technetium Tc 99m Exametazime (Ceretec)
|8.||Immunoglobulin G (IgG)
|9.||potassium borohydride (potassium tetrahydroborate)
|10.||stannous chloride (tin chloride)
|1.||Gamma Cameras (Gamma Camera)